Stock & Company Details
Agenus Inc $AGEN
Price:
N/A
N/A
45M
$278M
52 Week High:
N/A
10 Day Average Volume:
N/A
2.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
AGEN technical indicators
Latest Agenus Inc (AGEN) indicator readings as of 2026-11-19.
AGEN's 14-day RSI is 40.6, in neutral territory. ADX reads 19.1, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.21, below the zero line.
Overview
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Finance Bot
Ask your questions
Start by typing a question below.